Literature DB >> 17535990

Reduced sun exposure does not explain the inverse association of 25-hydroxyvitamin D with percent body fat in older adults.

Susan S Harris1, Bess Dawson-Hughes.   

Abstract

CONTEXT: Greater adiposity is associated with lower blood levels of 25-hydroxyvitamin D [25(OH)D]. The extent to which this results from reduced sun exposure among heavier individuals is unknown.
OBJECTIVES: This analysis was conducted to determine whether sun exposure habits differ according to percent body fat (%FAT) in older adults and to what extent they explain the inverse association of adiposity with 25(OH)D in that population.
DESIGN: We performed a cross-sectional analysis of baseline data from a randomized trial of calcium and vitamin D supplementation to prevent bone loss.
SETTING: The study was performed at the Metabolic Research Unit at the Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging at Tufts University. PARTICIPANTS: A total of 381 generally healthy male and female volunteers age 65 and older participated in the study. Exclusion criteria included vitamin D and calcium supplement use, and medical conditions and medications known to affect bone metabolism. INTERVENTION: There were no interventions. Measurements for this analysis were made before participants received trial supplements. MAIN OUTCOME MEASURES: Plasma 25(OH)D, an indicator of vitamin D status, was measured.
RESULTS: Sunscreen use, hours spent outside per week, and percent of skin exposed did not differ across quartiles of %FAT (P > 0.43). 25(OH)D decreased across %FAT quartiles (P < 0.05) and was about 20% lower in the highest compared with the lowest quartile of %FAT after adjustments for age, sex, season, and vitamin D intake. Further adjustment for sun exposure habits had little effect on estimates of 25(OH)D.
CONCLUSIONS: In older adults, sun exposure habits do not vary according to adiposity and do not appear to explain lower 25(OH)D concentrations with increasing adiposity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17535990     DOI: 10.1210/jc.2007-0722

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

1.  Vitamin D deficiency and calcium intake in reference to increased body mass index in children and adolescents.

Authors:  Sara Al-Musharaf; Abdulaziz Al-Othman; Nasser M Al-Daghri; Soundararajan Krishnaswamy; Deqa S Yusuf; Khalid M Alkharfy; Yousef Al-Saleh; Omar S Al-Attas; Majed S Alokail; Osama Moharram; Sobhy Yakout; Shaun Sabico; George P Chrousos
Journal:  Eur J Pediatr       Date:  2012-02-07       Impact factor: 3.183

2.  Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study.

Authors:  Rolf Jorde; Monica Sneve; Nina Emaus; Yngve Figenschau; Guri Grimnes
Journal:  Eur J Nutr       Date:  2010-03-04       Impact factor: 5.614

3.  Brazilian consensus on photoprotection.

Authors:  Sérgio Schalka; Denise Steiner; Flávia Naranjo Ravelli; Tatiana Steiner; Aripuanã Cobério Terena; Carolina Reato Marçon; Eloisa Leis Ayres; Flávia Alvim Sant'anna Addor; Helio Amante Miot; Humberto Ponzio; Ida Duarte; Jane Neffá; José Antônio Jabur da Cunha; Juliana Catucci Boza; Luciana de Paula Samorano; Marcelo de Paula Corrêa; Marcus Maia; Nilton Nasser; Olga Maria Rodrigues Ribeiro Leite; Otávio Sergio Lopes; Pedro Dantas Oliveira; Renata Leal Bregunci Meyer; Tânia Cestari; Vitor Manoel Silva dos Reis; Vitória Regina Pedreira de Almeida Rego
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

Review 4.  A dermatologist's perspective on vitamin D.

Authors:  Veena Vanchinathan; Henry W Lim
Journal:  Mayo Clin Proc       Date:  2012-03-14       Impact factor: 7.616

Review 5.  Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome.

Authors:  Richard C Strange; Kate E Shipman; Sudarshan Ramachandran
Journal:  World J Diabetes       Date:  2015-07-10

6.  The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.

Authors:  Joann E Manson; Shari S Bassuk; I-Min Lee; Nancy R Cook; Michelle A Albert; David Gordon; Elaine Zaharris; Jean G Macfadyen; Eleanor Danielson; Jennifer Lin; Shumin M Zhang; Julie E Buring
Journal:  Contemp Clin Trials       Date:  2011-10-02       Impact factor: 2.226

7.  VITAL-Bone Health: rationale and design of two ancillary studies evaluating the effects of vitamin D and/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL).

Authors:  Meryl S LeBoff; Amy Y Yue; Trisha Copeland; Nancy R Cook; Julie E Buring; JoAnn E Manson
Journal:  Contemp Clin Trials       Date:  2015-01-24       Impact factor: 2.226

Review 8.  Vitamin D and diabetes: let the sunshine in.

Authors:  Sue Penckofer; Joanne Kouba; Diane E Wallis; Mary Ann Emanuele
Journal:  Diabetes Educ       Date:  2008 Nov-Dec       Impact factor: 2.140

Review 9.  The noncalciotropic actions of vitamin D: recent clinical developments.

Authors:  Naim M Maalouf
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-07       Impact factor: 2.894

10.  Serum 25-hydroxyvitamin D is related to indicators of overall physical fitness in healthy postmenopausal women.

Authors:  Jeanne W Stewart; D Lee Alekel; Laura M Ritland; Marta Van Loan; Erik Gertz; Ulrike Genschel
Journal:  Menopause       Date:  2009 Nov-Dec       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.